Kerbl R - Search Results

1

Treatment complications in neuroblastoma patients: lessons from screening studies.

Kerbl R, Urban CE, Zotter H, Dornbusch HJ, Ladenstein R, Ambros IM, Ambros PF. Kerbl R, et al. J Clin Oncol. 2006 Jul 20;24(21):e41. doi: 10.1200/JCO.2006.06.8882. J Clin Oncol. 2006. PMID: 16849741 No abstract available.

2

Neuroblastoma screening in early life.

Kerbl R, Urban CE, Ambros PF. Kerbl R, et al. N Engl J Med. 2002 Sep 12;347(11):852-4; author reply 852-4. N Engl J Med. 2002. PMID: 12227369 No abstract available.

3

Neuroblastoma mass screening in late infancy: insights into the biology of neuroblastic tumors.

Kerbl R, Urban CE, Ambros IM, Dornbusch HJ, Schwinger W, Lackner H, Ladenstein R, Strenger V, Gadner H, Ambros PF. Kerbl R, et al. J Clin Oncol. 2003 Nov 15;21(22):4228-34. doi: 10.1200/JCO.2003.10.168. J Clin Oncol. 2003. PMID: 14615452

4

Clinical appearance of neuroblastoma 10 years after screening.

Kerbl R, Urban CE, Zotter H, Lackner H, Sovinz P, Ambros PF. Kerbl R, et al. Pediatr Blood Cancer. 2007 Dec;49(7):1012-4. doi: 10.1002/pbc.20828. Pediatr Blood Cancer. 2007. PMID: 16534792

5

Neuroblastoma mass screening in children.

Kerbl R, Urban CE. Kerbl R, et al. Lancet. 1997 Mar 8;349(9053):730. doi: 10.1016/S0140-6736(05)60170-5. Lancet. 1997. PMID: 9078223 No abstract available.

6

Neuroblastoma screening for children: delay, repeat, or delete?

Kerbl R, Urban CE, Ambros IM, Ambros PF. Kerbl R, et al. Med Pediatr Oncol. 1998 Aug;31(2):111-2. doi: 10.1002/(sici)1096-911x(199808)31:2<111::aid-mpo13>3.0.co;2-q. Med Pediatr Oncol. 1998. PMID: 9680938 No abstract available.

7

Neuroblastoma with focal MYCN amplification and bone marrow infiltration: a staging and treatment dilemma.

Kerbl R, Ambros IM, Ambros PF, Lackner H, Dornbusch HJ, Urban CE. Kerbl R, et al. Med Pediatr Oncol. 2002 Feb;38(2):109-11. doi: 10.1002/mpo.1281. Med Pediatr Oncol. 2002. PMID: 11813175 No abstract available.

8

Diagnostic and prognostic impact of urinary catecholamines in neuroblastoma patients.

Strenger V, Kerbl R, Dornbusch HJ, Ladenstein R, Ambros PF, Ambros IM, Urban C. Strenger V, et al. Among authors: kerbl r. Pediatr Blood Cancer. 2007 May;48(5):504-9. doi: 10.1002/pbc.20888. Pediatr Blood Cancer. 2007. PMID: 16732582

9

Neuroblastoma screening in infants postponed after the sixth month of age: a trial to reduce "overdiagnosis" and to detect cases with "unfavorable" biologic features.

Kerbl R, Urban CE, Ladenstein R, Ambros IM, Spuller E, Mutz I, Amann G, Kovar H, Gadner H, Ambros PF. Kerbl R, et al. Med Pediatr Oncol. 1997 Jul;29(1):1-10. doi: 10.1002/(sici)1096-911x(199707)29:1<1::aid-mpo1>3.0.co;2-j. Med Pediatr Oncol. 1997. PMID: 9142198

10

Neuroblastoma screening in the United States: results of the Texas Outreach Program for Neuroblastoma Screening.

Kerbl R, Urban C. Kerbl R, et al. Cancer. 1998 Nov 1;83(9):2047-8. doi: 10.1002/(sici)1097-0142(19981101)83:9<2047::aid-cncr27>3.0.co;2-n. Cancer. 1998. PMID: 9806668 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

187 results

Search Page

Filters